Double-binding botulinum molecule with reduced muscle paralysis: Evaluation in in vitro and in vivo models of migraine (2021)

First Author: Andreou A
Attributed to:  New non-paralytic botulinum molecules for the control of pain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.toxicon.2020.11.350

Publication URI: http://dx.doi.org/10.1016/j.toxicon.2020.11.350

Type: Journal Article/Review

Parent Publication: Toxicon